Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire

被引:43
|
作者
Padua, L
Evoli, A
Aprile, I
Caliandro, P
Batocchi, AP
Punzi, C
Mazza, S
Padua, R
Tonali, P
机构
[1] Univ Cattolica Sacro Cuore, Inst Neurol, I-00168 Rome, Italy
[2] Ist Don Gnocchi, Fdn Pro Iuventute, Rome, Italy
[3] San Giacomo Hosp, Dept Orthoped, Rome, Italy
[4] IRCCS Casa Solievo Sofferenza, San Giovanni Rotondo, FG, Italy
关键词
myasthenia gravis; patient-oriented; SF-36 self-administered questionnaire; disease-specific questionnaire; quality of life; validation;
D O I
10.1007/s100720200027
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe the development and validation of an outcome measure for patients with myasthenia gravis (MG) and show the correlation of the items with conventional MG measurements. In stage 1, item generation, a group of methodologists, clinical experts generated a list of 56 items. The list was based on (1) a previous study on an MG sample, (2) clinical experience and (3) items proposed by MG patients. In stage 2, reduction of items, the list was reduced on the basis of results from field testing (41 patients completed the 56-item questionnaire). In stage 3, reliability and validity were assessed. A 25-item MG questionnaire (MGQ) was generated. Results were related to conventional measures of MG severity. Furthermore, the MGQ appeared reliable, sensitive and reproducible. The questionnaire was validated as an outcome measure.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 50 条
  • [1] Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire
    L. Padua
    A. Evoli
    I. Aprile
    P. Caliandro
    A. P. Batocchi
    C. Punzi
    S. Mazza
    R. Padua
    P. Tonali
    Neurological Sciences, 2002, 23 : 59 - 68
  • [2] Development and Validation of a Self-Administered Questionnaire for Myasthenia Gravis Patients
    Maniaol, A. H.
    Brunborg, C.
    Tallaksen, C. M. E.
    NEUROEPIDEMIOLOGY, 2010, 34 (04) : 253 - 261
  • [3] Myasthenia gravis self-administered questionnaire: development of regional domains
    L. Padua
    G. Galassi
    A. Ariatti
    I. Aprile
    P. Caliandro
    A. Evoli
    C. Pazzaglia
    P. Tonali
    Neurological Sciences, 2005, 25 : 331 - 336
  • [4] Myasthenia gravis self-administered questionnaire: development of districtual domains
    Padua, L
    Galassi, G
    Ariatti, A
    Aprile, L
    Caliandro, P
    Evoli, A
    Pazzaglia, C
    Tonali, R
    JOURNAL OF NEUROLOGY, 2004, 251 : 16 - 16
  • [5] Myasthenia gravis self-administered questionnaire: development of regional domains
    Padua, L
    Galassi, G
    Ariatti, A
    Aprile, I
    Caliandro, P
    Evoli, A
    Pazzaglia, C
    Tonali, P
    NEUROLOGICAL SCIENCES, 2005, 25 (06) : 331 - 336
  • [6] Validation of Serbian version of the disease-specific myasthenia gravis questionnaire
    Basta, I.
    Pekmezovic, T.
    Padua, L.
    Stojanovic, V.
    Stevic, Z.
    Nikolic, A.
    Peric, S.
    Lavrnic, D.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (02): : 110 - 114
  • [7] Validation of the swedish version of the disease-specific myasthenia gravis questionnaire
    Rostedt, A
    Padua, L
    Stålberg, EV
    NEUROLOGICAL SCIENCES, 2006, 27 (02) : 91 - 96
  • [8] Validation of the Swedish version of the disease-specific Myasthenia Gravis Questionnaire
    A. Rostedt
    L. Padua
    E. V. Stålberg
    Neurological Sciences, 2006, 27 : 91 - 96
  • [9] Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect
    Salaffi, Fausto
    Sarzi-Puttini, Piercarlo
    Girolimetti, Rita
    Gasparini, Stefania
    Atzeni, Fabiola
    Grassi, Walter
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (04)
  • [10] Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect
    Fausto Salaffi
    Piercarlo Sarzi-Puttini
    Rita Girolimetti
    Stefania Gasparini
    Fabiola Atzeni
    Walter Grassi
    Arthritis Research & Therapy, 11